It was found that the blood glucose level in the HFD-DMSO group was significantly higher compared to the SCD group, while it decreased significantly after dapagliflozin gavage (Figure 3b), indicating that HFD could induce glucose tolerance impairment and dapagliflozin temporarily reduced the blood glucose in HFD-induced obese mice. Here, SCD is linked to glucose measurement.